Over the last 7 days, the Life Sciences industry has dropped 1.8%, driven by pullbacks in Thermo Fisher Scientific and Danaher of 3.0% and 2.9%, respectively. In the past year, the industry has gained 7.8%. As for the next few years, earnings are expected to grow by 17% per annum.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 29 May 2024 | US$726.8b | US$141.5b | US$12.4b | 38.7x | 58.5x | 5.1x |
Fri, 26 Apr 2024 | US$707.2b | US$141.7b | US$12.8b | 38.6x | 55.4x | 5x |
Sun, 24 Mar 2024 | US$749.2b | US$142.1b | US$12.8b | 44.7x | 58.4x | 5.3x |
Tue, 20 Feb 2024 | US$720.7b | US$142.2b | US$12.5b | 43.3x | 57.5x | 5.1x |
Thu, 18 Jan 2024 | US$675.0b | US$153.8b | US$14.2b | 35.1x | 47.6x | 4.4x |
Sat, 16 Dec 2023 | US$684.6b | US$153.7b | US$14.2b | 37.1x | 48.1x | 4.5x |
Mon, 13 Nov 2023 | US$585.8b | US$153.8b | US$14.0b | 30.9x | 42x | 3.8x |
Wed, 11 Oct 2023 | US$649.2b | US$154.6b | US$11.2b | 33.4x | 57.9x | 4.2x |
Fri, 08 Sep 2023 | US$705.5b | US$154.6b | US$11.2b | 32x | 63x | 4.6x |
Sun, 06 Aug 2023 | US$724.6b | US$154.7b | US$11.3b | 30.2x | 64.4x | 4.7x |
Tue, 04 Jul 2023 | US$691.6b | US$152.4b | US$12.5b | 29.6x | 55.3x | 4.5x |
Thu, 01 Jun 2023 | US$666.2b | US$152.2b | US$12.5b | 27.2x | 53.3x | 4.4x |
Sat, 29 Apr 2023 | US$699.2b | US$152.9b | US$9.4b | 29.2x | 74.1x | 4.6x |
Mon, 27 Mar 2023 | US$705.3b | US$154.5b | US$10.8b | 26.1x | 65.2x | 4.6x |
Wed, 22 Feb 2023 | US$725.6b | US$154.2b | US$11.0b | 31x | 66.2x | 4.7x |
Fri, 20 Jan 2023 | US$757.2b | US$155.3b | US$8.5b | 30.6x | 88.8x | 4.9x |
Sun, 18 Dec 2022 | US$742.7b | US$155.2b | US$8.8b | 28.5x | 84.6x | 4.8x |
Tue, 15 Nov 2022 | US$764.2b | US$154.9b | US$8.8b | 28.1x | 86.6x | 4.9x |
Thu, 13 Oct 2022 | US$691.5b | US$152.5b | US$17.0b | 23.1x | 40.7x | 4.5x |
Sat, 10 Sep 2022 | US$800.7b | US$152.3b | US$17.3b | 30.6x | 46.3x | 5.3x |
Mon, 08 Aug 2022 | US$830.4b | US$151.9b | US$18.2b | 33.6x | 45.6x | 5.5x |
Wed, 06 Jul 2022 | US$731.2b | US$148.1b | US$20.1b | 31x | 36.4x | 4.9x |
Fri, 03 Jun 2022 | US$744.1b | US$148.1b | US$20.1b | 30.6x | 37x | 5x |
Sun, 01 May 2022 | US$773.3b | US$150.7b | US$21.1b | 31.2x | 36.7x | 5.1x |
Tue, 29 Mar 2022 | US$866.9b | US$146.0b | US$25.4b | 36x | 34.2x | 5.9x |
Thu, 24 Feb 2022 | US$820.4b | US$146.1b | US$25.3b | 36.9x | 32.4x | 5.6x |
Sat, 22 Jan 2022 | US$837.1b | US$138.0b | US$27.3b | 39.3x | 30.6x | 6.1x |
Mon, 20 Dec 2021 | US$964.3b | US$138.0b | US$27.3b | 44.7x | 35.3x | 7x |
Wed, 17 Nov 2021 | US$956.4b | US$137.8b | US$27.1b | 46.2x | 35.3x | 6.9x |
Fri, 15 Oct 2021 | US$707.0b | US$106.0b | US$18.5b | 46.5x | 38.1x | 6.7x |
Sun, 12 Sep 2021 | US$749.6b | US$106.0b | US$18.6b | 48.9x | 40.3x | 7.1x |
Tue, 10 Aug 2021 | US$709.4b | US$105.8b | US$18.7b | 46.5x | 38x | 6.7x |
34.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.58% | |
Healthcare | -2.29% | |
Life Sciences | -2.75% | |
Clinical Research and Equipment | -2.75% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ICLR ICON | US$321.06 | 1.0% +US$262.9m | 54.0% | PE38.9x | |
ABCL AbCellera Biologics | US$4.08 | 6.0% +US$67.6m | -41.3% | PS33.5x | |
STVN Stevanato Group | US$19.50 | 1.2% +US$65.5m | -26.7% | PE36x | |
SHC Sotera Health | US$11.04 | 1.4% +US$42.5m | -21.4% | PE57.3x | |
SYNH Syneos Health | US$42.98 | 0.6% +US$24.9m | -8.8% | PE62.6x |